First Time Loading...
S

Shanghai Haishun New Pharmaceutical Packaging Co Ltd
SZSE:300501

Watchlist Manager
Shanghai Haishun New Pharmaceutical Packaging Co Ltd
SZSE:300501
Watchlist
Price: 12.48 CNY -2.35% Market Closed
Updated: May 12, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

2.9B
+0.7%
Assets
Growth Rates:
1 Year
+23%
3 Years
+123%
5 Years
+229%
7 Years
+364%
10 Years
-
1.1B
-3%
Liabilities
Growth Rates:
1 Year
+36%
3 Years
+104%
5 Years
+322%
7 Years
+1 401%
10 Years
-
1.8B
+3%
Equity
Growth Rates:
1 Year
+16%
3 Years
+136%
5 Years
+192%
7 Years
+231%
10 Years
-

Balance Sheet Decomposition
Shanghai Haishun New Pharmaceutical Packaging Co Ltd

2.9B
Assets
1.1B
Liabilities
2.9B
Assets
1.1B
Liabilities
Current Assets 1.2B
Cash & Short-Term Investments 656.8m
Receivables 305.9m
Other Current Assets 252.9m
Non-Current Assets 1.7B
Long-Term Investments 394.4m
PP&E 995.5m
Intangibles 129.4m
Other Non-Current Assets 171.6m
Current Liabilities 391.3m
Accounts Payable 103.7m
Accrued Liabilities 7.7m
Short-Term Debt 185.9m
Other Current Liabilities 94m
Non-Current Liabilities 678.7m
Long-Term Debt 549m
Other Non-Current Liabilities 129.8m

Balance Sheet
Shanghai Haishun New Pharmaceutical Packaging Co Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022
Assets
Cash & Cash Equivalents
31
71
94
107
116
64
55
71
613
302
Cash
0
0
0
0
0
0
0
0
613
302
Cash Equivalents
31
71
94
107
116
64
55
71
0
0
Short-Term Investments
0
0
0
0
0
0
29
11
29
31
Total Receivables
94
96
108
132
154
225
291
331
289
344
Accounts Receivables
82
83
80
113
121
159
165
186
200
273
Other Receivables
13
14
28
20
33
66
126
145
89
72
Inventory
33
26
24
42
63
106
114
117
161
193
Other Current Assets
2
3
1
204
135
120
36
25
30
29
Total Current Assets
160
197
227
485
466
515
526
555
1 122
899
PP&E Net
80
74
94
138
217
341
364
497
753
877
PP&E Gross
80
74
94
138
217
341
364
497
753
877
Accumulated Depreciation
25
32
38
51
61
106
131
161
179
215
Intangible Assets
16
15
15
14
14
73
107
104
131
127
Goodwill
0
0
0
1
3
5
5
5
4
4
Long-Term Investments
0
0
0
0
0
1
226
237
241
375
Other Long-Term Assets
2
2
3
45
10
9
8
8
13
22
Other Assets
0
0
0
1
3
5
5
5
4
4
Total Assets
257
N/A
288
+12%
339
+18%
684
+102%
710
+4%
943
+33%
1 235
+31%
1 406
+14%
2 264
+61%
2 305
+2%
Liabilities
Accounts Payable
18
14
13
23
33
48
66
79
137
102
Accrued Liabilities
3
3
3
3
4
7
6
8
19
30
Short-Term Debt
24
26
33
47
24
74
304
302
295
239
Current Portion of Long-Term Debt
0
0
0
0
0
16
16
16
15
63
Other Current Liabilities
9
6
11
10
8
28
42
33
23
28
Total Current Liabilities
54
48
60
82
69
174
433
437
490
462
Long-Term Debt
0
0
0
0
0
49
33
75
165
126
Minority Interest
2
2
2
22
22
70
69
71
76
83
Other Liabilities
8
8
8
8
8
5
6
16
24
39
Total Liabilities
63
N/A
58
-8%
70
+21%
111
+60%
98
-12%
298
+204%
541
+82%
600
+11%
754
+26%
709
-6%
Equity
Common Stock
40
40
40
53
67
101
157
157
194
194
Retained Earnings
87
123
162
200
239
271
307
402
499
578
Additional Paid In Capital
68
68
68
320
306
273
260
265
825
825
Treasury Stock
0
0
0
0
0
0
30
18
7
0
Other Equity
0
0
0
0
0
0
0
0
0
0
Total Equity
194
N/A
231
+19%
269
+17%
573
+113%
612
+7%
645
+5%
694
+8%
805
+16%
1 510
+88%
1 597
+6%
Total Liabilities & Equity
257
N/A
288
+12%
339
+18%
684
+102%
710
+4%
943
+33%
1 235
+31%
1 406
+14%
2 264
+61%
2 305
+2%
Shares Outstanding
Common Shares Outstanding
113
113
113
151
151
151
156
156
193
194

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 136,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.